Intron retention is a robust marker of intertumoral heterogeneity in pancreatic ductal adenocarcinoma
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a 5-year survival rate of <8%. Unsupervised clustering of 76 PDAC patients based on intron retention (IR) events resulted in two clusters of tumors (IR-1 and IR-2). While gene expression-based clusters are not predictiv...
Guardado en:
Autores principales: | Daniel J. Tan, Mithun Mitra, Alec M. Chiu, Hilary A. Coller |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fc3a0c8629c1439484ba57658f1cc672 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Robust deep learning model for prognostic stratification of pancreatic ductal adenocarcinoma patients
por: Jie Ju, et al.
Publicado: (2021) -
Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
por: Hongjin Wu, et al.
Publicado: (2021) -
Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Eric M. Anderson, et al.
Publicado: (2021) -
Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma
por: Xingyi Pan, et al.
Publicado: (2021) -
IRFinder-S: a comprehensive suite to discover and explore intron retention
por: Claudio Lorenzi, et al.
Publicado: (2021)